290,935 Shares in Humana Inc. $HUM Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 290,935 shares of the insurance provider's stock, valued at approximately $115,565,000. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.24% of Humana at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Capital International Investors grew its position in shares of Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Norges Bank bought a new stake in Humana in the 4th quarter valued at about $456,632,000. Pzena Investment Management LLC lifted its position in Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider's stock valued at $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. Wellington Management Group LLP boosted its stake in Humana by 4,481.7% during the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider's stock valued at $306,460,000 after purchasing an additional 1,170,387 shares during the period. Finally, Franklin Resources Inc. grew its position in Humana by 914.5% in the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider's stock worth $321,613,000 after purchasing an additional 1,131,893 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have commented on HUM. Truist Financial raised their price target on shares of Humana from $320.00 to $415.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. Guggenheim boosted their price objective on Humana from $269.00 to $471.00 and gave the stock a "buy" rating in a research report on Thursday, July 30th. Bank of America raised Humana from a "neutral" rating to a "buy" rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th. Piper Sandler upgraded Humana from a "hold" rating to an "overweight" rating and set a $463.00 target price on the stock in a research report on Thursday, July 30th. Finally, Zacks Research downgraded Humana from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $395.22.

Humana Trading Down 0.6%

Humana stock opened at $382.13 on Wednesday. The firm has a 50 day simple moving average of $382.93 and a 200-day simple moving average of $278.32. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a market capitalization of $45.89 billion, a PE ratio of 36.15, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analysts' expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm's quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.27 earnings per share. As a group, equities research analysts expect that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source